Product Information
VRAYLAR 1.5 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $50.9159 per EA under NDC 61874011530. Its NADAC has been published 519 times since Jul 20, 2016.
Strength
1.5 mg/1
Manufacturer
Allergan, Inc.NDC
61874011530
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARIPRAZINEApproval Type
New Drug (NDA)
FDA Application
NDA204370On Market Since
9/17/2015
Pharmacological Classes
Price Statistics
The NADAC for VRAYLAR 1.5 MG CAPSULE has been published 519 times since Jul 20, 2016, and over the history we have for it it has risen 57.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $50.9159 per EA |
|---|---|
| All-time high | $50.9650 (May 13, 2026) |
| All-time low | $32.1408 (Aug 17, 2016) |
| 52-week high | $50.9650 |
| 52-week low | $48.5296 |
| Median price | $40.4828 |
| Average price | $41.2980 |
| Largest weekly change | +9.5% (Jan 10, 2018) |
| Weeks tracked | 519 |
| Tracking since | Jul 20, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VRAYLAR 1.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VRAYLAR 1.5 MG CAPSULE, manufactured by Allergan, Inc., is $50.9159 per EA (NDC 61874011530), effective Jun 24, 2026.
How has the price of VRAYLAR 1.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VRAYLAR 1.5 MG CAPSULE has risen 57.2%. It has been tracked across 519 weekly CMS publications since Jul 20, 2016.
What are the highest and lowest recorded NADAC prices for VRAYLAR 1.5 MG CAPSULE?
Since Jul 20, 2016, the NADAC for VRAYLAR 1.5 MG CAPSULE has ranged from a low of $32.1408 (Aug 17, 2016) to a high of $50.9650 (May 13, 2026), with a median of $40.4828 per EA.
Are there cheaper alternatives to VRAYLAR 1.5 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VRAYLAR 1.5 MG CAPSULE, but none are currently priced below it.
Who manufactures VRAYLAR 1.5 MG CAPSULE?
VRAYLAR 1.5 MG CAPSULE (NDC 61874011530) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification